A story in Thursday's issue of MDD about a study on opportunities in the peripheral vascular disease market issued by Scientia Advisors did not mean to imply that the study was a direct outgrowth of a project being done for one of the firm's clients. The company said the study grew out of its own interest in potential opportunities for companies in the PVD space.